Onno Akkerman

Zoekresultaten

• 2022

  The Effect of COVID-19 Infection on Transplant Function and Development of CLAD in Lung Transplant Patients: A Multicenter Experience

  Roosma, E., Van Gemert, J. P., De Zwart, A. E., Van Leer-Buter, C. C., Hellemons, M. E., Berg, E., Luijk, B., Akkerman, O. W., Verschuuren, E. A. & Gan, C. T., apr.-2022, In: Journal of Heart and Lung Transplantation. 41, 4, blz. S110-S111 2 blz.

  Onderzoeksoutput › Academic
• 2019

  Changes in body composition and strength during initial treatment in malnourished patients with tuberculosis

  De Reus, Y. A., Ter Beek, L., Van Der Werf, T. S. & Akkerman, O. W., 28-sep.-2019, In: European Respiratory Journal. 54, 2 blz.

  Onderzoeksoutput › Academic

• National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey

  Bothamley, G. H., Andre, E., Kuksa, L., Barkana, L., Keane, J., Veziris, N., Van Crevel, R., Magis-Escurra, C., Jankovic, M., Schoch, O., Zellweger, J.-P., Vasankari, T., Eyuboglu, F., Holland, R., Normark, J., Macedo, R., Korzeniewska, M., Nanovoc, Z., Butov, D. & Akkerman, O. & 28 anderen, Kirakosyan, O., Solovic, I., Calcagno, A., Kruczak, K., Garcia Garcia, J. M., Montalva, A. S., Dyatlov, A., Starshinova, A., Kulcitkaia, S., Lillebaek, T., Wiese, L., Hafizi, H., Papaventis, D., Heldel, E., Arnesen, T. M., Lanoix, J.-P., Chiappini, E., Wejse, C., Manika, K., Pesut, D., Wetzstein, N., Skrahina, A., Flick, H., Arias, M., Konstantynovska, O., Millet, J. P., Bakker, M. & Lange, C., 28-sep.-2019, In: European Respiratory Journal. 54, 4 blz.

  Onderzoeksoutput › Academic

• Remarkable outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands, and factors associated with mortality and treatment default

  Gafar, F., Boveneind-Vrubleuskaya, van 't, N., Akkerman, O., Wilffert, B. & Alffenaar, J.-W., nov.-2019, In: International Journal of Tuberculosis and Lung Disease. 22, 11, blz. S143 1 blz.

  Onderzoeksoutput › Academic

• Sensitivity and Specificity of an Electronic Nose in Diagnosing Pulmonary Tuberculosis Among Patients with Suspected Tuberculosis in Indonesia

  Saktiawati, A., Stienstra, Y., Subronto, Y. W., Sumardi, S., Gerritsen, J., Oord, H., Akkerman, O. W. & van der Werf, T. S., 2019, In: American Journal of Respiratory and Critical Care Medicine. 199, 2 blz.

  Onderzoeksoutput › Academic
• 2018

  Development and validation of a prediction model for poor outcome of tuberculosis treatment: A nationwide, register-based retrospective cohort study from the Netherlands

  Pradipta, I. S., van't Boveneind-Vrubleuskaya, N., Akkerman, O. W., Alffenaar, J.-W. & Hak, E., aug.-2018, In: Pharmacoepidemiology and Drug Safety. 27, blz. 477 1 blz.

  Onderzoeksoutput › Academic
• 2016

  Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients

  Hoppentocht, M., Akkerman, O. W., Hagedoorn, P., Alffenaar, J.-W. C., van der Werf, T. S., Kerstjens, H. A. M., Frijlink, H. W. & de Boer, A. H., jun.-2016, In: Journal of aerosol medicine and pulmonary drug delivery. 29, 3, blz. A22-A23 2 blz.

  Onderzoeksoutput › Academic

• In vitro evaluation of the Twincer colistin dry powder inhaler as a non-cough-inducing alternative to Colobreathe

  Hagedoorn, P., Grasmeijer, F., Hoppentocht, M., Akkerman, O., Frijlink, H. & De Boer, A., 1-sep.-2016, In: European Respiratory Journal. 48, Suppl.60

  Onderzoeksoutput › Academic

  Open Access

  • Dry Powder Inhaler 100%
  • Colistimethate 100%
  • Coughing 100%
  • Inhalation Volume 50%
  • Fine Aerosol 50%